Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Inventory: 2018-2025

Historic Change in Inventory for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to -$938,000.

  • Organogenesis Holdings' Change in Inventory fell 125.08% to -$938,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 138.71%. This contributed to the annual value of $6.2 million for FY2024, which is 24.15% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Change in Inventory stood at -$938,000, which was down 113.10% from $7.2 million recorded in Q2 2025.
  • Organogenesis Holdings' Change in Inventory's 5-year high stood at $8.7 million during Q1 2025, with a 5-year trough of -$2.7 million in Q2 2024.
  • For the 3-year period, Organogenesis Holdings' Change in Inventory averaged around $2.7 million, with its median value being $2.2 million (2023).
  • Per our database at Business Quant, Organogenesis Holdings' Change in Inventory spiked by 2,803.75% in 2023 and then crashed by 241.39% in 2024.
  • Organogenesis Holdings' Change in Inventory (Quarterly) stood at -$439,000 in 2021, then surged by 584.74% to $2.1 million in 2022, then slumped by 66.82% to $706,000 in 2023, then slumped by 35.55% to $455,000 in 2024, then plummeted by 125.08% to -$938,000 in 2025.
  • Its last three reported values are -$938,000 in Q3 2025, $7.2 million for Q2 2025, and $8.7 million during Q1 2025.